Name: Drugs Looking for Diseases: Innovative Drug Research and the Development of the Beta Blockers and the Calcium Antagonists (en Inglés)
Price: 1391.67 MXN
Availability: InStock
Author: Vos, R.
ISBN: 9789401056892

Envío gratis

portada Drugs Looking for Diseases: Innovative Drug Research and the Development of the Beta Blockers and the Calcium Antagonists (en Inglés)

Formato

Libro Físico

Autor

R. Vos

Editorial

Springer

Idioma

Inglés

N° páginas

381

Encuadernación

Tapa Blanda

Dimensiones

23.4 x 15.6 x 2.2 cm

Peso

0.58 kg.

ISBN13

9789401056892

Categorías

Ética médica y conducta profesional
Enfermedades cardiovasculares

Drugs Looking for Diseases: Innovative Drug Research and the Development of the Beta Blockers and the Calcium Antagonists (en Inglés)

R. Vos (Autor) · Springer · Tapa Blanda

Libro Nuevo

$ 1,391.67

$ 2,319.45

Ahorras: $ 927.78

40% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 22 de Julio y el Martes 30 de Julio.

Lo recibirás en cualquier lugar de México entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Drugs Looking for Diseases: Innovative Drug Research and the Development of the Beta Blockers and the Calcium Antagonists (en Inglés)"

We all know how much time, effort and money it takes to develop a new drug. Hundreds of chemical compounds have to be synthesized and thousands of different activities in biology, physiology, pharmacology, clinical investigation, management and marketing have to be initiated and coordinated. Each new drug starts a voyage of discovery through an unmapped terrain which is shrouded in mist and beset by pitfalls, as Dr. Rein Vos puts it in his absorbing inside story of the development of the beta-adrenoceptor blocking agents and the calcium antagonists. Indeed we know, for example, how long it took before the theory of Ahlquist of the alpha and beta adrenergic receptors was widely accepted. Similarly, it suffices to memorize shortly the difficulty of expanding the new concept of calcium antagonism through the national German boundaries into the world. This shows how laborious and complex pharmaceutical progress is, and we all will benefit from a deeper understanding of the process of innovative drug research.